The oncogenic
transcription factor AP-1 (activator protein-1) is required for
tumor promotion and progression. Identification of novel and specific
AP-1 inhibitors would be beneficial for
cancer prevention and
therapy. The authors have developed a high-throughput assay to screen synthetic and
natural product libraries for noncytotoxic inhibitors of
mitogen-activated
AP-1 activity. The cell-based high-throughput screen is conducted in a 384-well format using a fluorescent resonance energy transfer (FRET) substrate to quantify the activity of a
beta-lactamase reporter under the control of an AP-1-dependent promoter. The ratiometric FRET readout makes this assay extremely robust and reproducible, particularly for use with
natural product extracts. To eliminate false positives due to cell killing, a cytotoxicity assay was incorporated. The
AP-1 beta-lactamase reporter was validated with inhibitors of
kinases located upstream of
AP-1 and with known
natural product inhibitors of
AP-1 (
nordihydroguaiaretic acid and
curcumin). The assay was able to identify other known
AP-1 inhibitors and
protein kinase C modulators, as well as a number of chemically diverse compounds with unknown mechanisms of action from natural products libraries. Application to
natural product extracts identified hits from a range of taxonomic groups. Screening of synthetic compounds and natural products should identify novel
AP-1 inhibitors that may be useful in the prevention and treatment of
cancers.